Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:18 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Metabolism
Interventions: No Music, Relaxing Classical Music, Self-Selected Relaxing Music; Other
Lead sponsor: Old Dominion University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Cocaine Abuse
Interventions: L-dopa / carbidopa / entacapone (LCE); Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 50 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: End Stage Renal Disease (ESRD)
Interventions: soluble ferric pyrophosphate (SFP), placebo; Drug · Other
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Los Angeles, California • Louisville, Kentucky

Conditions: Cardiovascular Fitness
Interventions: Preventive treatment; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 30 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Elderly
Interventions: GHRH; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years to 85 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Baltimore, Maryland • Boston, Massachusetts

Conditions: Altitude Hypoxia
Interventions: Hypoxic breathing conditions; Other
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 18 Years to 40 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Dystonia, Focal, Task-specific
Interventions: rTMS, Sham rTMS; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Renal Cell Carcinoma
Interventions: AirSeal® System-Interventional, Conventional Insufflator and Trocar; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2014
U.S. locations: 1
States / cities: Orange, California

Conditions: Chronic Urogenital Pain
Interventions: Life-Stress Interview; Behavioral
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Hemodynamic Monitoring
Interventions: Noninvasive Hemodynamic Monitoring System; Device
Lead sponsor: AcQumen Medical, Inc.; Industry
Eligibility: 2 Months to 95 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Riverside, Connecticut

Conditions: Vulvovaginal Atrophy
Interventions: WC3011 Estradiol Vaginal Cream, Vehicle; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 35 Years and older · Female only
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 57
States / cities: Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 48 more

Conditions: Oxytocin, Labor Pain, Induction of Labor Affected Fetus / Newborn, Physiologic Effects of Drugs
Interventions: Electric breast pump, Exogenous oxytocin intravenous infusion without nipple stimulation.; Device · Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 933 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2029
U.S. locations: 3
States / cities: New Haven, Connecticut • Chicago, Illinois • New York, New York

Conditions: Food Insecurity
Interventions: High-Stress Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 453 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Endometriosis
Interventions: 75 mg linzagolix tablet, 200 mg linzagolix tablet, Add-back capsule (E2 1 mg / NETA 0.5 mg), Placebo tablet to match 75 mg linzagolix tablet, Placebo tablet to match 200 mg linzagolix tablet, Placebo capsule to match Add-back capsule; Drug
Lead sponsor: Kissei Pharmaceutical Co., Ltd.; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 23
States / cities: Little Rock, Arkansas • Norwalk, California • Greenwood Village, Colorado + 17 more

Conditions: Anterior Cruciate Ligament Reconstruction, Regional Anesthesia, Saphenous Nerve Block
Interventions: Bupivacaine Only, Bupivacaine with 1 mg of Dexamethasone, Bupivacaine with 4 mg of Dexamethasone; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 16 Years to 65 Years
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Sexual Dysfunction, Sexual Arousal Disorder, Sexual Dysfunction, Physiological, Breast Cancer, Nipple Disorder, Neuropathy, Cancer of Breast
Interventions: AB-101, Placebo; Drug
Lead sponsor: Applied Biology, Inc.; Industry
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Stress, Emotional
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Sexual Dysfunction
Interventions: OMGYES.com; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Pain
Interventions: CR845, Placebo; Drug
Lead sponsor: Cara Therapeutics, Inc.; Industry
Eligibility: 21 Years to 60 Years · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 12
States / cities: Mobile, Alabama • Sheffield, Alabama • Phoenix, Arizona + 7 more

Conditions: Depression, Unipolar
Interventions: Intravenous Ketamine; Drug
Lead sponsor: Jay Fournier; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Post-acute Sequelae of SARS-CoV-2 Infection
Interventions: Exercise; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: type1diabetes, Obesity
Interventions: Hyperinsulinemic-euglycemic clamp, High Fat Mixed Meal Tolerance Test; Biological · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Respiratory Remote Patient Monitor (Spire Health Tag); Device
Lead sponsor: Spire, Inc.; Industry
Eligibility: Not listed
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: Mito-Food Plan, Cellular Repair Therapy; Dietary Supplement · Other
Lead sponsor: Perseverance Research Center, LLC; Other
Eligibility: 55 Years to 90 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Scottsdale, Arizona

Search by objective public record fields.

Physiological and Perceptual Effects of Music on Resting Metabolic Rate (RMR)

Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)

Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients

Adaptations to 4-s Sprint Interval Training at Different Intensities

Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly

The Physiological Effects of Acute and Ramp Simulated Altitude Exposure During Simulated Flight Tasks

Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia

A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation

Life-Stress Interview for Women With Chronic Urogenital Pain Conditions

Evaluation of the UltraTrac System as a Non-Invasive Monitor of Hemodynamic Parameters

Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

The Stimulation To Induce Mothers Study

Cortisol and Food Insecurity

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain

Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

My Health Day by Day (Mi Salud Dia a Dia)

AYA OMGYES Sexual Health Study

Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

Repeated Neurocognitive Measurements in Depressed Patients

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

Effect of Remote Physiologic Monitoring (RPM) on Outcomes in COPD Patients

Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients